Russia has started producing CoviVac, its third vaccine against COVID-19.
The new vaccine will soon be made available for use in its regions, though phase three trials are still under way, officials said on Thursday.
The most well-known Russian coronavirus vaccine is Sputnik V. Moscow has also given emergency approval to two shots, EpiVacCorona and CoviVac.
"The third Russian vaccine is entering civilian circulation and will appear in the regions in the coming days," the Science and Higher Education Ministry said in a statement.
The Chumakov Centre plans to produce up to 10 million doses of the vaccine a year, the ministry said.
Science Minister Valery Falkov said that phase three trials of the vaccine had begun, the Interfax news agency reported.
The Chumakov Centre's director said phase three trials would be completed within half a year, Interfax reported.
US proposes plan to end Iran war, as Trump signals progress
US expected to send thousands more soldiers to Middle East
US safety agency says tracking system failed at LaGuardia during jet collision
Russia fires record 948 drones against Ukraine over 24 hours, Kyiv says
Death toll rises to 69 in Colombian military plane crash
One killed, five injured in Bahrain from Iran strikes
Qatar is not directly mediating between US and Iran, ministry spokesperson says
Germany, France in rare rebuke of Trump over Iran war
